Cefpodoxime

Also known as: Cefpodoxime Acid, CPDX, Cefpodoxime Proxetil EP Impurity A, (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, U 76253A

Cefpodoxime (CAS 80210-62-4) is a compound in the Organic Compounds category listed in the Jingsj chemical database. It has the molecular formula C15H17N5O6S2 and a molecular weight of 427.455 g/mol. Key properties include a melting point of 200-202ºC and a density of 1.8±0.1 g/cm3. It is classified under GHS with signal word Danger and hazard statements H317 — May cause an allergic skin reaction and H334 — May cause allergy or asthma symptoms if inhaled. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.

CAS No.: 80210-62-4
Jingsj CID: J-1962779-3
Molecular Formula: C₁₅H₁₇N₅O₆S₂
Molecular Weight: 427.455 g/mol
Category: Organic Compounds
Last updated: 8/21/2026

Request MSDS / TDS

No offers for this compound yet.

Request a quote

Physicochemical Properties

Melting Point	200-202ºC
Density	1.8±0.1 g/cm3
Exact Mass	427.062012
PSA	209.98000
LogP	0.94
Refractive Index	1.780

GHS Safety & Compliance

Health HazardSignal word: Danger

H317 — May cause an allergic skin reaction
H334 — May cause allergy or asthma symptoms if inhaled

Activity & Biological Data

Additional Information	[1]. Werner H, et, al. Comparative in vitro activity of cefpodoxime against anaerobes other than Bacteroides fragilis. Infection. 1991 Sep-Oct;19(5):377-9. [2]. Valentini S, et, al. In-vitro evaluation of cefpodoxime. J Antimicrob Chemother. 1994 Mar;33(3):495-508. [3]. Pérez-Trallero E, et, al. Prediction of in-vivo efficacy by in-vitro early bactericidal activity with oral beta-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin. J Chemother. 2001 Apr;13(2):118-25.

Additional Information

[1]. Werner H, et, al. Comparative in vitro activity of cefpodoxime against anaerobes other than Bacteroides fragilis. Infection. 1991 Sep-Oct;19(5):377-9. [2]. Valentini S, et, al. In-vitro evaluation of cefpodoxime. J Antimicrob Chemother. 1994 Mar;33(3):495-508. [3]. Pérez-Trallero E, et, al. Prediction of in-vivo efficacy by in-vitro early bactericidal activity with oral beta-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin. J Chemother. 2001 Apr;13(2):118-25.

Frequently Asked Questions

What is the CAS number of Cefpodoxime?

The CAS number of Cefpodoxime is 80210-62-4.

What are the molecular formula and molecular weight of Cefpodoxime?

Cefpodoxime has molecular formula C15H17N5O6S2 and molecular weight 427.455 g/mol.

Is Cefpodoxime hazardous?

Cefpodoxime has GHS signal word Danger and hazard statements H317 — May cause an allergic skin reaction; H334 — May cause allergy or asthma symptoms if inhaled.

What are the upstream and downstream products of Cefpodoxime?

For Cefpodoxime, Upstream Products: S-2-Benzothiazolyl 2-amino-alpha-(methoxyimino)-4-thiazolethiolacetate, (6R,7R)-7-Amino-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-Aminocephalosporanic acid; Downstream Products: Cefpodoxime Proxetil.

Data compiled from public chemical databases such as PubChem and supplier catalogs; supplier offers are provided by suppliers.

Last updated: 8/21/2026

How to cite: Jingsj. "Cefpodoxime (CAS 80210-62-4)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-1962779-3 (accessed 2026-11-09).

Data for reference only; verify product details with suppliers before purchase.